Aclaris Therapeutics, Inc. (ACRS)
3.615
+1.00
(+37.98%)
USD |
NASDAQ |
Jan 20, 11:36
Aclaris Therapeutics Market Cap: 391.67M for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Corcept Therapeutics, Inc. | 3.656B |
| Puma Biotechnology, Inc. | 329.05M |
| Nephros, Inc. | 47.82M |
| Prelude Therapeutics, Inc. | 121.96M |
| Vivos Therapeutics, Inc. | 18.61M |
Market Cap Related Metrics
| PS Ratio | 26.57 |
| PEG Ratio | -0.0157 |
| Price to Book Value | 3.261 |
| Price | 3.615 |
| Earnings Yield | -38.21% |
| PEGY Ratio | -0.0157 |